Showing posts with label Eli Lilly. Show all posts
Showing posts with label Eli Lilly. Show all posts

Tuesday, July 24, 2007

Stock futures seen mixed, earnings in focus

(Reuters) - The Indicative Dow Jones industrial average, which tracks the 30 index blue chips as they are traded on the Deutsche Boerse's electronic trading platform, XETRA, and translates the prices into dollars, was 0.19 percent lower.




Earnings reports are due from companies including online retailer Amazon.com Inc. , drugmaker Eli Lilly & Co. and hamburger chain McDonald's Corp. .


Read more at Reuters.com Business News

Tuesday, July 10, 2007

Moody's weighs ratings as drug-patent lapses near

(Reuters) - Eli Lilly and Co. , Pfizer Inc. and
Bristol-Myers Squibb Co. are particularly vulnerable to
the downgrades because the top-selling drug of each expires in
that period.




Merck & Co. could also be adversely affected as two
of its important drugs face patent expirations.


Read more at Reuters.com Bonds News

Monday, June 11, 2007

Barr withdraws patent suit related to generic Zyprexa

(Reuters) - This follows the decision of a U.S appeals court to uphold
a trial court's verdict in favor of Eli Lilly in a patent suit
related to Zyprexa against Zenith Goldline Pharmaceuticals
Inc., Teva Pharmaceuticals USA Inc.




Read more at Reuters.com Government Filings News